PMC:7152526 / 16365-16949
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
376 | 73-81 | Species | denotes | patients | Tax:9606 |
377 | 164-172 | Species | denotes | patients | Tax:9606 |
378 | 575-583 | Species | denotes | patients | Tax:9606 |
379 | 106-114 | Disease | denotes | COVID-19 | MESH:C000657245 |
380 | 115-124 | Disease | denotes | infection | MESH:D007239 |
381 | 566-574 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T113 | 61-67 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T114 | 425-431 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T115 | 544-550 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T103 | 106-114 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T104 | 115-124 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T105 | 566-574 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T164 | 61-67 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T165 | 425-431 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T166 | 544-550 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T75 | 247-262 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T76 | 343-358 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20 | 318-339 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory response |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T118 | 0-216 | Sentence | denotes | Despite the limitations, our cases suggest that convalescent plasma from patients who have recovered from COVID-19 infection might be an additional option to treat patients without causing any severe adverse effects. |
T119 | 217-447 | Sentence | denotes | Also, when used with systemic corticosteroids, we might expect the possibility of reducing excessive inflammatory response by corticosteroids as well as promoting the reduction of viral loads by convalescent plasma simultaneously. |
T120 | 448-584 | Sentence | denotes | Further well-designed studies are needed to demonstrate the efficacy and safety of convalescent plasma transfusion in COVID-19 patients. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T264 | 61-67 | UBERON:0001969 | denotes | plasma |
T265 | 106-114 | SP_7 | denotes | COVID-19 |
T266 | 247-262 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T267 | 343-358 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T268 | 397-402 | NCBITaxon:10239 | denotes | viral |
T269 | 425-431 | UBERON:0001969 | denotes | plasma |
T270 | 544-550 | UBERON:0001969 | denotes | plasma |
T271 | 566-574 | SP_7 | denotes | COVID-19 |
T31952 | 61-67 | UBERON:0001969 | denotes | plasma |
T56557 | 106-114 | SP_7 | denotes | COVID-19 |
T11836 | 247-262 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T92146 | 343-358 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T78664 | 397-402 | NCBITaxon:10239 | denotes | viral |
T21512 | 425-431 | UBERON:0001969 | denotes | plasma |
T78481 | 544-550 | UBERON:0001969 | denotes | plasma |
T93841 | 566-574 | SP_7 | denotes | COVID-19 |